These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8391054)

  • 1. Splenic macrophage activation and functions in amyloid enhancing factor-induced secondary amyloidosis. Study of phagocytosis, killing, respiratory burst, and MHC class II surface expression.
    Reid C; Hébert L; Pozzulo G; Gervais F
    J Leukoc Biol; 1993 Jun; 53(6):651-7. PubMed ID: 8391054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
    Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
    Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster.
    Hol PR; Snel FW; Niewold TA; Gruys E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):273-81. PubMed ID: 2879382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis.
    Shtrasburg S; Pras M; Brezniak N; Dolitzki M; Livneh A
    J Lab Clin Med; 1999 Aug; 134(2):168-72. PubMed ID: 10444031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. apo-SAA1/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice mice.
    Hébert L; Gervais F
    Scand J Immunol; 1990 Feb; 31(2):167-73. PubMed ID: 2309099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F; Hébert L; Skamene E
    J Leukoc Biol; 1988 Apr; 43(4):311-6. PubMed ID: 3162509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.
    Abankwa GV; Ali-Khan Z
    Br J Exp Pathol; 1988 Feb; 69(1):123-32. PubMed ID: 3348956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.
    Kennel SJ; Macy S; Wooliver C; Huang Y; Richey T; Heidel E; Wall JS
    Amyloid; 2014 Mar; 21(1):45-53. PubMed ID: 24446872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of amyloid enhancing factor: clinical and experimental implications.
    Shtrasburg S; Pras M; Brezniak N; Livneh A
    Clin Exp Rheumatol; 1998; 16(3):299-302. PubMed ID: 9631753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis.
    Elliott-Bryant R; Cathcart ES
    Clin Immunol Immunopathol; 1998 Jul; 88(1):65-9. PubMed ID: 9683551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
    Kisilevsky R; Tan R; Subrahmanyan L; Snow A
    Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the carbocyclic nucleoside analogue MDL 201,112 on inhibition of interferon-gamma-induced priming of Lewis (LEW/N) rat macrophages for enhanced respiratory burst and MHC class II Ia+ antigen expression.
    Edwards CK; Watts LM; Parmely MJ; Linnik MD; Long RE; Borcherding DR
    J Leukoc Biol; 1994 Aug; 56(2):133-44. PubMed ID: 8071590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.